CRA International, Inc. (CRAI)
NASDAQIndustrialsConsulting ServicesSnapshot 2026-10-29
$196.08-0.35%
Close 2026-10-30 · 1-day change
NASDAQIndustrialsConsulting ServicesSnapshot 2026-10-29
Research Workspace
Put CRAI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrials is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisManagement screens strong on capital allocation.
View ManagementExpectations look high — the market is pricing in about 42% growth a year, above the roughly 6% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 1% on a typical day and fell roughly 38% in its worst 12-month stretch.
View RiskCRAI’s case rests on steady financial performance, with reported-profit quality remaining fragile. Revenue grew 12.8% year over year, and Q2 FY2026 earnings beat consensus. CRAI trades at 24× P/E versus a 23× peer median and 21× its historical multiple. The market is pricing in more growth than our forecast. Weak cash backing and an expensive valuation threaten the premium, despite an 18% next-quarter miss probability. Peer multiples imply a price about 42% below where it trades; our read remains intact, and this read is provisional.
Trailing returns as of 2026-10-30. CRAI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 2 analysts currently covering CRAI (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare CRAI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CRAI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Research & Consulting Services — fair value, gap to price, and forward P/E.
Compare the value case
Put CRAI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand and diversify consulting practices with broad-based growth
Broad-based practice growth supports management's expansion objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Earnings call confirms strong performance and outlook.
Exceeding forecasts supports revenue growth expectations.
Advances: Maintain revenue guidance of $785M to $805M for 2026
Record quarter supports revenue growth objective.
Threatens: Maintain non-GAAP EBITDA margin guidance of 12% to 13% for 2026
Margin compression poses risk to EBITDA margin guidance.